Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: Spectrum of antimicrobial activity and measurements of bactericidal activity

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 8, 2004, Pages 3112-3118

  Sader, Helio S ^a,b   Fedler, Kelley A ^a   Rennie, Robert P ^c   Stevens, Shelley ^c   Jones, Ronald N ^a  

^a JMI LABORATORIES   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; CIPROFLOXACIN; GENTAMICIN; MBI 226; NEOMYCIN; OFLOXACIN; OMIGANAN; OXACILLIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; UNCLASSIFIED DRUG; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BETA HEMOLYTIC STREPTOCOCCUS; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORYNEBACTERIUM; DRUG ACTIVITY; ENTEROBACTER; ESCHERICHIA COLI; FUNGUS; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; CANDIDA; CANDIDIASIS; COLONY COUNT, MICROBIAL; DRUG STABILITY; FREEZING; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; OXACILLIN; PENICILLIN RESISTANCE; PENICILLINS; VANCOMYCIN RESISTANCE;

EID: 3342924083     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.8.3112-3118.2004     Document Type: Article

References (12)

1. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
2. Cormican, M. G., and M. A. Pfaller. 1996. Standardization of antifungal susceptibility testing. J. Antimicrob. Chemother. 38:561-578.
3. Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. W. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086-2092.
4. Hindler, J. (ed.). 1992. Antimicrobial susceptibility testing, p. 5-0-1-5-25-1. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 1, American Society for Microbiology, Washington, D.C.
5. Isaacson, R. E. 2003, MBI-226. Micrologix/Fujisawa. Curt. Opin. Investig. Drugs 4:999-1003.
6. McConnell, S. A., P. O. Gubbins, and E. J. Anaissie. 2003. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin. Infect. Dis. 37:65-72.
7. McGee, D. C., and M. K. Gould. 2003. Preventing complications of central venous catheterization. N. Engl. J. Med. 348:1123-1133,
8. National Committee for Clinical Laboratory Standards. 1999. Methodology for the serum bactericidal test. Approved guideline. Document M21-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents, Approved guideline. Document M26-A. National Committee for Clinical Laboratory Standards, Wayne, Pa,
10. National Committee for Clinical Laboratory Standards. 2000. Reference method for broth microdilution antifungal susceptibility testing of yeasts. Approved standard, 2nd ed. Document M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 6th ed, Document M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing: 13th informational supplement. Document M100-S13. National Committee for Clinical Laboratory Standards, Wayne, Pa.